Related Experiment Video
Updated: Mar 28, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
SOX4 Is Essential for Prostate Tumorigenesis Initiated by PTEN Ablation
Birdal Bilir1, Adeboye O Osunkoya2, W Guy Wiles3
1Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia.
Abstract:
Understanding remains incomplete of the mechanisms underlying initiation and progression of prostate cancer, the most commonly diagnosed cancer in American men. The transcription factor SOX4 is overexpressed in many human cancers, including prostate cancer, suggesting it may participate in prostate tumorigenesis. In this study, we investigated this possibility by genetically deleting Sox4 in a mouse model of prostate cancer initiated by loss of the tumor suppressor Pten. We found that specific homozygous deletion of Sox4 in the adult prostate epithelium strongly inhibited tumor progression initiated by homozygous loss of Pten. Mechanistically, Sox4 ablation reduced activation of AKT and β-catenin, leading to an attenuated invasive phenotype. Furthermore, SOX4 expression was induced by Pten loss as a result of the activation of PI3K-AKT-mTOR signaling, suggesting a positive feedback loop between SOX4 and PI3K-AKT-mTOR activity. Collectively, our findings establish that SOX4 is a critical component of the PTEN/PI3K/AKT pathway in prostate cancer, with potential implications for combination-targeted therapies against both primary and advanced prostate cancers.
Insights
SOX4 is crucial for prostate cancer progression. Its removal in mice with Pten loss significantly inhibited tumor growth by reducing AKT and beta-catenin activation, highlighting SOX4 as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Prostate cancer initiation and progression mechanisms are not fully understood.
- SOX4, a transcription factor, is overexpressed in various cancers, including prostate cancer.
- SOX4's role in prostate tumorigenesis requires further investigation.
Purpose of the Study:
- To investigate the role of SOX4 in prostate cancer development.
- To determine if SOX4 deletion impacts tumor progression in a mouse model.
- To elucidate the molecular mechanisms by which SOX4 influences prostate cancer.
Main Methods:
- Genetic deletion of Sox4 in a mouse model of prostate cancer.
- Induction of prostate cancer by homozygous loss of the tumor suppressor Pten.
- Analysis of AKT and beta-catenin activation pathways.
Main Results:
- Homozygous deletion of Sox4 significantly inhibited prostate tumor progression.
- Sox4 ablation reduced AKT and beta-catenin activation, attenuating invasiveness.
- Pten loss induced SOX4 expression via PI3K-AKT-mTOR signaling, indicating a feedback loop.
Conclusions:
- SOX4 is a critical mediator in the PTEN/PI3K/AKT pathway in prostate cancer.
- Targeting SOX4 may offer therapeutic strategies for both primary and advanced prostate cancers.
- Findings suggest a positive feedback loop involving SOX4 and PI3K-AKT-mTOR signaling in prostate tumorigenesis.
More Related Videos
10:38Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Published on: November 22, 2019
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Pleiotropy
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions